{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:41:08Z","timestamp":1788946868023,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 106-2410-H-006-039-MY2"],"award-info":[{"award-number":["MOST 106-2410-H-006-039-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2628-B-037-002 -"],"award-info":[{"award-number":["MOST 107-2628-B-037-002 -"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Monoamine neurotransmitters play essential roles in the regulation of arousal and sleep. Impaired metabolism of monoamine neurotransmitters could result in the accumulation of neurotoxic aldehyde metabolites and, hence, neuronal degeneration. Aldehyde dehydrogenases play an important role in the metabolism of the neurotoxic aldehyde metabolites, including the aldehyde metabolites of dopamine, serotonin, and noradrenaline. Deficient aldehyde dehydrogenase 2 (ALDH2) has been suggested to result in the accumulation of these biogenic aldehydes. An <jats:italic>ALDH2<\/jats:italic> single nucleotide polymorphism (SNP), rs671 (A), results in significantly reduced ALDH2 enzyme activity. A total of 83 Parkinson\u2019s disease (PD) patients were recruited in this study. In addition to the genotypes of rs671, the patients were assessed with the PD sleep scale-2nd version (PDSS-2) and the Epworth sleepiness scale (ESS) for symptoms of daytime and nocturnal sleep disturbances. The patients carrying rs671 (A) had more frequent dozing while lying down to rest in the afternoon (ESS item5) (F\u2009=\u20097.308, p\u2009=\u20090.008) than the rs671 (GG) patients. The patients with rs671 (A) reported a trend toward more frequent difficulty staying asleep than the patients with rs671 (GG). (F\u2009=\u20093.278, p\u2009=\u20090.074). The results indicate that patients carrying allele rs671 (A) are more likely to experience impairment in the regulation of arousal and sleep. The results also support the hypothesis that the accumulation of neurotoxic monoamine neurotransmitter aldehyde metabolites secondary to reduced ALDH2 enzyme activity may cause more severe monoaminergic neuronal loss and, hence, more severe symptoms in the regulation of wakefulness and sleep.<\/jats:p>","DOI":"10.1038\/s41598-019-55427-w","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T15:11:38Z","timestamp":1576163498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Effect of ALDH2 on Sleep Disturbances in Patients with Parkinson\u2019s Disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Chia-Yen","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5836-1237","authenticated-orcid":false,"given":"Rwei-Ling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruey-Meei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6950-4678","authenticated-orcid":false,"given":"Chun-Hsiang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"55427_CR1","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim, T., Jette, N., Frolkis, A. & Steeves, T. D. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Movement disorders: official journal of the Movement Disorder. Society 29, 1583\u20131590, https:\/\/doi.org\/10.1002\/mds.25945 (2014).","journal-title":"Society"},{"key":"55427_CR2","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/ene.12950","volume":"23","author":"KM Prakash","year":"2016","unstructured":"Prakash, K. M., Nadkarni, N. V., Lye, W. K., Yong, M. H. & Tan, E. K. The impact of non-motor symptoms on the quality of life of Parkinson\u2019s disease patients: a longitudinal study. European journal of neurology: the official journal of the European Federation of Neurological Societies 23, 854\u2013860, https:\/\/doi.org\/10.1111\/ene.12950 (2016).","journal-title":"European journal of neurology: the official journal of the European Federation of Neurological Societies"},{"key":"55427_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/ncpneuro0775","volume":"4","author":"VC De Cock","year":"2008","unstructured":"De Cock, V. C., Vidailhet, M. & Arnulf, I. Sleep disturbances in patients with parkinsonism. Nat Clin Pract Neurol 4, 254\u2013266, https:\/\/doi.org\/10.1038\/ncpneuro0775 (2008).","journal-title":"Nat Clin Pract Neurol"},{"key":"55427_CR4","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2147\/ndt.s85483","volume":"11","author":"RL Yu","year":"2015","unstructured":"Yu, R. L., Tan, C. H. & Wu, R. M. The impact of nocturnal disturbances on daily quality of life in patients with Parkinson\u2019s disease. Neuropsychiatric disease and treatment 11, 2005\u20132012, https:\/\/doi.org\/10.2147\/ndt.s85483 (2015).","journal-title":"Neuropsychiatric disease and treatment"},{"key":"55427_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jns.2016.12.062","volume":"374","author":"KA Ehgoetz Martens","year":"2017","unstructured":"Ehgoetz Martens, K. A. & Lewis, S. J. Pathology of behavior in PD: What is known and what is not? Journal of the neurological sciences 374, 9\u201316, https:\/\/doi.org\/10.1016\/j.jns.2016.12.062 (2017).","journal-title":"Journal of the neurological sciences"},{"key":"55427_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1212\/WNL.0b013e3181ec7fac","volume":"75","author":"DO Claassen","year":"2010","unstructured":"Claassen, D. O. et al. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 75, 494\u2013499, https:\/\/doi.org\/10.1212\/WNL.0b013e3181ec7fac (2010).","journal-title":"Neurology"},{"key":"55427_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiology of aging 24, 197\u2013211 (2003).","journal-title":"Neurobiology of aging"},{"key":"55427_CR8","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2010.11.032","volume":"68","author":"CB Saper","year":"2010","unstructured":"Saper, C. B., Fuller, P. M., Pedersen, N. P., Lu, J. & Scammell, T. E. Sleep state switching. Neuron 68, 1023\u20131042, https:\/\/doi.org\/10.1016\/j.neuron.2010.11.032 (2010).","journal-title":"Neuron"},{"key":"55427_CR9","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/S0021-9258(18)99864-9","volume":"241","author":"VG Erwin","year":"1966","unstructured":"Erwin, V. G. & Deitrich, R. A. Brain aldehyde dehydrogenase. Localization, purification, and properties. The Journal of biological chemistry 241, 3533\u20133539 (1966).","journal-title":"The Journal of biological chemistry"},{"key":"55427_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000028400","volume":"61","author":"V Vasiliou","year":"2000","unstructured":"Vasiliou, V. & Pappa, A. Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease. Pharmacology 61, 192\u2013198, https:\/\/doi.org\/10.1159\/000028400 (2000).","journal-title":"Pharmacology"},{"key":"55427_CR11","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0009-2797(00)00245-3","volume":"130-132","author":"WM Keung","year":"2001","unstructured":"Keung, W. M. Biogenic aldehyde(s) derived from the action of monoamine oxidase may mediate the antidipsotropic effect of daidzin. Chemico-biological interactions 130-132, 919\u2013930 (2001).","journal-title":"Chemico-biological interactions"},{"key":"55427_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1124\/pr.59.2.1","volume":"59","author":"SA Marchitti","year":"2007","unstructured":"Marchitti, S. A., Deitrich, R. A. & Vasiliou, V. Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase. Pharmacological reviews 59, 125\u2013150, https:\/\/doi.org\/10.1124\/pr.59.2.1 (2007).","journal-title":"Pharmacological reviews"},{"key":"55427_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1073\/pnas.81.1.258","volume":"81","author":"A Yoshida","year":"1984","unstructured":"Yoshida, A., Huang, I. Y. & Ikawa, M. Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proceedings of the National Academy of Sciences of the United States of America 81, 258\u2013261 (1984).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"55427_CR14","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S0140-6736(81)91172-7","volume":"2","author":"S Harada","year":"1981","unstructured":"Harada, S., Agarwal, D. P. & Goedde, H. W. Aldehyde dehydrogenase deficiency as cause of facial flushing reaction to alcohol in Japanese. Lancet (London, England) 2, 982 (1981).","journal-title":"Lancet (London, England)"},{"key":"55427_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s0161-813x(03)00090-1","volume":"25","author":"WJ Burke","year":"2004","unstructured":"Burke, W. J. et al. Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases. Neurotoxicology 25, 101\u2013115, https:\/\/doi.org\/10.1016\/s0161-813x(03)00090-1 (2004).","journal-title":"Neurotoxicology"},{"key":"55427_CR16","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner, B. et al. In vivo demonstration that alpha-synuclein oligomers are toxic. Proceedings of the National Academy of Sciences of the United States of America 108, 4194\u20134199, https:\/\/doi.org\/10.1073\/pnas.1100976108 (2011).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"55427_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neulet.2015.01.064","volume":"590","author":"Y Jinsmaa","year":"2015","unstructured":"Jinsmaa, Y., Cooney, A., Sullivan, P., Sharabi, Y. & Goldstein, D. S. The serotonin aldehyde, 5-HIAL, oligomerizes alpha-synuclein. Neuroscience letters 590, 134\u2013137, https:\/\/doi.org\/10.1016\/j.neulet.2015.01.064 (2015).","journal-title":"Neuroscience letters"},{"key":"55427_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep30424","volume":"6","author":"RL Yu","year":"2016","unstructured":"Yu, R. L., Tan, C. H., Lu, Y. C. & Wu, R. M. Aldehyde dehydrogenase 2 is associated with cognitive functions in patients with Parkinson\u2019s disease. Scientific reports 6, 30424, https:\/\/doi.org\/10.1038\/srep30424 (2016).","journal-title":"Scientific reports"},{"key":"55427_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.parkreldis.2014.02.013","volume":"20","author":"R Mehanna","year":"2014","unstructured":"Mehanna, R., Moore, S., Hou, J. G., Sarwar, A. I. & Lai, E. C. Comparing clinical features of young onset, middle onset and late onset Parkinson\u2019s disease. Parkinsonism & related disorders 20, 530\u2013534, https:\/\/doi.org\/10.1016\/j.parkreldis.2014.02.013 (2014).","journal-title":"Parkinsonism & related disorders"},{"key":"55427_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/mds.23469","volume":"26","author":"MM Wickremaratchi","year":"2011","unstructured":"Wickremaratchi, M. M. et al. The motor phenotype of Parkinson\u2019s disease in relation to age at onset. Movement disorders: official journal of the Movement Disorder. Society 26, 457\u2013463, https:\/\/doi.org\/10.1002\/mds.23469 (2011).","journal-title":"Society"},{"key":"55427_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/mdc3.12063","volume":"1","author":"EYH Yeung","year":"2014","unstructured":"Yeung, E. Y. H. & Cavanna, A. E. Sleep Attacks in Patients With Parkinson\u2019s Disease on Dopaminergic Medications: A Systematic Review. Movement disorders clinical practice 1, 307\u2013316, https:\/\/doi.org\/10.1002\/mdc3.12063 (2014).","journal-title":"Movement disorders clinical practice"},{"key":"55427_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1172\/jci113875","volume":"83","author":"DW Crabb","year":"1989","unstructured":"Crabb, D. W., Edenberg, H. J., Bosron, W. F. & Li, T. K. Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant. The Journal of clinical investigation 83, 314\u2013316, https:\/\/doi.org\/10.1172\/jci113875 (1989).","journal-title":"The Journal of clinical investigation"},{"key":"55427_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/acer.12215","volume":"38","author":"CL Lai","year":"2014","unstructured":"Lai, C. L. et al. Dominance of the inactive Asian variant over activity and protein contents of mitochondrial aldehyde dehydrogenase 2 in human liver. Alcoholism, clinical and experimental research 38, 44\u201350, https:\/\/doi.org\/10.1111\/acer.12215 (2014).","journal-title":"Alcoholism, clinical and experimental research"},{"issue":"7687","key":"55427_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nature25154","volume":"553","author":"Juan I. Garaycoechea","year":"2018","unstructured":"Garaycoechea, J. I. et al. Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells. Nature 553, 171, https:\/\/doi.org\/10.1038\/nature25154, https:\/\/www.nature.com\/articles\/nature25154#supplementary-information (2018).","journal-title":"Nature"},{"key":"55427_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12929-017-0327-y","volume":"24","author":"JS Chang","year":"2017","unstructured":"Chang, J. S., Hsiao, J. R. & Chen, C. H. ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective. J Biomed Sci 24, 19, https:\/\/doi.org\/10.1186\/s12929-017-0327-y (2017).","journal-title":"J Biomed Sci"},{"issue":"4","key":"55427_CR26","first-page":"111","volume":"25","author":"CH Chen","year":"2016","unstructured":"Chen, C. H., Joshi, A. U. & Mochly-Rosen, D. The Role of Mitochondrial Aldehyde Dehydrogenase 2 (ALDH2) in Neuropathology and Neurodegeneration. Acta neurologica Taiwanica 25(4), 111\u2013123 (2016).","journal-title":"Acta neurologica Taiwanica"},{"key":"55427_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00017.2013","volume":"94","author":"CH Chen","year":"2014","unstructured":"Chen, C. H., Ferreira, J. C., Gross, E. R. & Mochly-Rosen, D. Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiological reviews 94, 1\u201334, https:\/\/doi.org\/10.1152\/physrev.00017.2013 (2014).","journal-title":"Physiological reviews"},{"key":"55427_CR28","doi-asserted-by":"publisher","first-page":"e0192229","DOI":"10.1371\/journal.pone.0192229","volume":"13","author":"RB Lu","year":"2018","unstructured":"Lu, R. B. et al. The aldehyde dehydrogenase 2 polymorphisms on neuropsychological performance in bipolar II disorder with or without comorbid anxiety disorder. PloS one 13, e0192229, https:\/\/doi.org\/10.1371\/journal.pone.0192229 (2018).","journal-title":"PloS one"},{"key":"55427_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1006\/abio.1999.4196","volume":"273","author":"WJ Burke","year":"1999","unstructured":"Burke, W. J., Chung, H. D. & Li, S. W. Quantitation of 3, 4-dihydroxyphenylacetaldehyde and 3, 4-dihydroxyphenylglycolaldehyde, the monoamine oxidase metabolites of dopamine and noradrenaline, in human tissues by microcolumn high-performance liquid chromatography. Analytical biochemistry 273, 111\u2013116, https:\/\/doi.org\/10.1006\/abio.1999.4196 (1999).","journal-title":"Analytical biochemistry"},{"key":"55427_CR30","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0891-5849(01)00484-1","volume":"30","author":"BS Kristal","year":"2001","unstructured":"Kristal, B. S. et al. Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. Free radical biology & medicine 30, 924\u2013931 (2001).","journal-title":"Free radical biology & medicine"},{"key":"55427_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/s0161-813x(03)00148-7","volume":"25","author":"H Legros","year":"2004","unstructured":"Legros, H., Dingeval, M. G., Janin, F., Costentin, J. & Bonnet, J. J. Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: relationships with 3,4-dihydroxyphenylacetaldehyde formation. Neurotoxicology 25, 365\u2013375, https:\/\/doi.org\/10.1016\/s0161-813x(03)00148-7 (2004).","journal-title":"Neurotoxicology"},{"key":"55427_CR32","doi-asserted-by":"crossref","unstructured":"Lamensdorf, I. et al. Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde. Journal of neuroscience research 60, 552\u2013558, doi:10.1002\/(sici)1097-4547(20000515)60:4<552::aid-jnr14>3.0.co;2-u (2000).","DOI":"10.1002\/(SICI)1097-4547(20000515)60:4<552::AID-JNR14>3.0.CO;2-U"},{"key":"55427_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/1055-8330(95)90016-0","volume":"4","author":"MB Mattammal","year":"1995","unstructured":"Mattammal, M. B., Haring, J. H., Chung, H. D., Raghu, G. & Strong, R. An endogenous dopaminergic neurotoxin: implication for Parkinson\u2019s disease. Neurodegeneration: a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 4, 271\u2013281 (1995).","journal-title":"Neurodegeneration: a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration"},{"key":"55427_CR34","doi-asserted-by":"publisher","first-page":"e15251","DOI":"10.1371\/journal.pone.0015251","volume":"5","author":"WM Panneton","year":"2010","unstructured":"Panneton, W. M., Kumar, V. B., Gan, Q., Burke, W. J. & Galvin, J. E. The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis. PloS one 5, e15251, https:\/\/doi.org\/10.1371\/journal.pone.0015251 (2010).","journal-title":"PloS one"},{"key":"55427_CR35","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/0006-8993(96)00129-1","volume":"722","author":"WJ Burke","year":"1996","unstructured":"Burke, W. J., Schmitt, C. A., Gillespie, K. N. & Li, S. W. Norepinephrine transmitter metabolite is a selective cell death messenger in differentiated rat pheochromocytoma cells. Brain research 722, 232\u2013235 (1996).","journal-title":"Brain research"},{"key":"55427_CR36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0006-8993(00)03199-1","volume":"891","author":"WJ Burke","year":"2001","unstructured":"Burke, W. J. et al. Catecholamine monoamine oxidase a metabolite in adrenergic neurons is cytotoxic in vivo. Brain research 891, 218\u2013227 (2001).","journal-title":"Brain research"},{"key":"55427_CR37","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1021\/jm990614i","volume":"43","author":"N Rooke","year":"2000","unstructured":"Rooke, N., Li, D. J., Li, J. & Keung, W. M. The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin. Journal of medicinal chemistry 43, 4169\u20134179 (2000).","journal-title":"Journal of medicinal chemistry"},{"key":"55427_CR38","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.conb.2017.03.021","volume":"44","author":"CB Saper","year":"2017","unstructured":"Saper, C. B. & Fuller, P. M. Wake-sleep circuitry: an overview. Current opinion in neurobiology 44, 186\u2013192, https:\/\/doi.org\/10.1016\/j.conb.2017.03.021 (2017).","journal-title":"Current opinion in neurobiology"},{"key":"55427_CR39","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1523\/JNEUROSCI.01-08-00876.1981","volume":"1","author":"G Aston-Jones","year":"1981","unstructured":"Aston-Jones, G. & Bloom, F. E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. The Journal of neuroscience: the official journal of the Society for Neuroscience 1, 876\u2013886 (1981).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"55427_CR40","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/nn.2682","volume":"13","author":"ME Carter","year":"2010","unstructured":"Carter, M. E. et al. Tuning arousal with optogenetic modulation of locus coeruleus neurons. Nature neuroscience 13, 1526\u20131533, https:\/\/doi.org\/10.1038\/nn.2682 (2010).","journal-title":"Nature neuroscience"},{"key":"55427_CR41","doi-asserted-by":"publisher","first-page":"E2635","DOI":"10.1073\/pnas.1202526109","volume":"109","author":"ME Carter","year":"2012","unstructured":"Carter, M. E. et al. Mechanism for Hypocretin-mediated sleep-to-wake transitions. Proceedings of the National Academy of Sciences of the United States of America 109, E2635\u20132644, https:\/\/doi.org\/10.1073\/pnas.1202526109 (2012).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"55427_CR42","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/sj.npp.1301251","volume":"32","author":"L Dahan","year":"2007","unstructured":"Dahan, L. et al. Prominent burst firing of dopaminergic neurons in the ventral tegmental area during paradoxical sleep. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 32, 1232\u20131241, https:\/\/doi.org\/10.1038\/sj.npp.1301251 (2007).","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"key":"55427_CR43","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/nn.4377","volume":"19","author":"A Eban-Rothschild","year":"2016","unstructured":"Eban-Rothschild, A., Rothschild, G., Giardino, W. J., Jones, J. R. & de Lecea, L. VTA dopaminergic neurons regulate ethologically relevant sleep-wake behaviors. Nature neuroscience 19, 1356\u20131366, https:\/\/doi.org\/10.1038\/nn.4377 (2016).","journal-title":"Nature neuroscience"},{"key":"55427_CR44","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.neuron.2017.05.020","volume":"94","author":"JR Cho","year":"2017","unstructured":"Cho, J. R. et al. Dorsal Raphe Dopamine Neurons Modulate Arousal and Promote Wakefulness by Salient Stimuli. Neuron 94, 1205\u20131219.e1208, https:\/\/doi.org\/10.1016\/j.neuron.2017.05.020 (2017).","journal-title":"Neuron"},{"key":"55427_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03889-3","volume":"9","author":"YJ Luo","year":"2018","unstructured":"Luo, Y. J. et al. Nucleus accumbens controls wakefulness by a subpopulation of neurons expressing dopamine D1 receptors. Nature communications 9, 1576, https:\/\/doi.org\/10.1038\/s41467-018-03889-3 (2018).","journal-title":"Nature communications"},{"key":"55427_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0006-8993(79)90157-4","volume":"163","author":"ME Trulson","year":"1979","unstructured":"Trulson, M. E. & Jacobs, B. L. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain research 163, 135\u2013150 (1979).","journal-title":"Brain research"},{"key":"55427_CR47","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1523\/JNEUROSCI.16-08-02820.1996","volume":"16","author":"CM Portas","year":"1996","unstructured":"Portas, C. M., Thakkar, M., Rainnie, D. & McCarley, R. W. Microdialysis perfusion of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the dorsal raphe nucleus decreases serotonin release and increases rapid eye movement sleep in the freely moving cat. The Journal of neuroscience: the official journal of the Society for Neuroscience 16, 2820\u20132828 (1996).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"55427_CR48","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nature04767","volume":"441","author":"J Lu","year":"2006","unstructured":"Lu, J., Sherman, D., Devor, M. & Saper, C. B. A putative flip-flop switch for control of REM sleep. Nature 441, 589\u2013594, https:\/\/doi.org\/10.1038\/nature04767 (2006).","journal-title":"Nature"},{"key":"55427_CR49","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1006\/exnr.1997.6418","volume":"144","author":"DA McRitchie","year":"1997","unstructured":"McRitchie, D. A., Cartwright, H. R. & Halliday, G. M. Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson\u2019s disease. Experimental neurology 144, 202\u2013213, https:\/\/doi.org\/10.1006\/exnr.1997.6418 (1997).","journal-title":"Experimental neurology"},{"key":"55427_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","volume":"5","author":"SL Alberico","year":"2015","unstructured":"Alberico, S. L., Cassell, M. D. & Narayanan, N. S. The Vulnerable Ventral Tegmental Area in Parkinson\u2019s Disease. Basal ganglia 5, 51\u201355, https:\/\/doi.org\/10.1016\/j.baga.2015.06.001 (2015).","journal-title":"Basal ganglia"},{"key":"55427_CR51","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/jnnp-2011-301817","volume":"84","author":"K Del Tredici","year":"2013","unstructured":"Del Tredici, K. & Braak, H. Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson\u2019s disease-related dementia. Journal of neurology, neurosurgery, and psychiatry 84, 774\u2013783, https:\/\/doi.org\/10.1136\/jnnp-2011-301817 (2013).","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"key":"55427_CR52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/bf03159935","volume":"14","author":"KA Jellinger","year":"1991","unstructured":"Jellinger, K. A. Pathology of Parkinson\u2019s disease. Molecular and Chemical Neuropathology 14, 153\u2013197, https:\/\/doi.org\/10.1007\/bf03159935 (1991).","journal-title":"Molecular and Chemical Neuropathology"},{"key":"55427_CR53","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/archneur.60.3.337","volume":"60","author":"C Zarow","year":"2003","unstructured":"Zarow, C., Lyness, S. A., Mortimer, J. A. & Chui, H. C. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Archives of neurology 60, 337\u2013341 (2003).","journal-title":"Archives of neurology"},{"key":"55427_CR54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. Journal of neurology, neurosurgery, and psychiatry 55, 181\u2013184 (1992).","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"key":"55427_CR55","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson, C. L. et al. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Movement disorders: official journal of the Movement Disorder. Society 25, 2649\u20132653, https:\/\/doi.org\/10.1002\/mds.23429 (2010).","journal-title":"Society"},{"key":"55427_CR56","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/mdc3.12349","volume":"4","author":"RL Yu","year":"2017","unstructured":"Yu, R. L. et al. Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society- Unified Parkinson\u2019s Disease Rating Scale. Movement disorders clinical practice 4, 68\u201377, https:\/\/doi.org\/10.1002\/mdc3.12349 (2017).","journal-title":"Movement disorders clinical practice"},{"key":"55427_CR57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn, M. M. & Yahr, M. D. Parkinsonism: onset, progression and mortality. Neurology 17, 427\u2013442 (1967).","journal-title":"Neurology"},{"key":"55427_CR58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jns.2008.03.008","volume":"271","author":"K Suzuki","year":"2008","unstructured":"Suzuki, K. et al. Excessive daytime sleepiness and sleep episodes in Japanese patients with Parkinson\u2019s disease. Journal of the neurological sciences 271, 47\u201352, https:\/\/doi.org\/10.1016\/j.jns.2008.03.008 (2008).","journal-title":"Journal of the neurological sciences"},{"key":"55427_CR59","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1023\/A:1020818417949","volume":"11","author":"NH Chen","year":"2002","unstructured":"Chen, N. H. et al. Validation of a Chinese version of the Epworth sleepiness scale. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation 11, 817\u2013821 (2002).","journal-title":"Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation"},{"key":"55427_CR60","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/mds.23476","volume":"26","author":"C Trenkwalder","year":"2011","unstructured":"Trenkwalder, C. et al. Parkinson\u2019s disease sleep scale\u2013validation of the revised version PDSS-2. Movement disorders: official journal of the Movement Disorder Society 26, 644\u2013652, https:\/\/doi.org\/10.1002\/mds.23476 (2011).","journal-title":"Movement disorders: official journal of the Movement Disorder Society"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55427-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55427-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55427-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T17:27:21Z","timestamp":1671298041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55427-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["55427"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-55427-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"assertion":[{"value":"16 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18950"}}